Clinical Nuclear Cardiology: State of the Art and Future Directions Book

Ch. 1	Overview of kinetics and modeling	3
Ch. 2	Kinetics on a cellular level	13
Ch. 3	Role of intact biological models for evaluation of radiotracers	25
Ch. 4	Single-photon emission computed tomography processing, quantification, and display	51
Ch. 5	Single-photon emission computed tomography artifacts	67
Ch. 6	Attenuation/scatter/resolution correction : physics aspects	89
Ch. 7	Attenuation/scatter correction : clinical aspects	103
Ch. 8	Dynamic cardiac single-photon emission computed tomography using fast data acquisition systems	117
Ch. 9	The new generation positron emission tomography/computed tomography scanners : implications for cardiac imaging	141
Ch. 10	State of the art instrumentation for positron emission tomography and single-photon emission computed tomography imaging in small animals	153
Ch. 11	Cardiac performance	175
Ch. 12	Regional and global ventricular function and volumes from single-photon emission computed tomography perfusion imaging	189
Ch. 13	Coronary artery disease : exercise stress	215
Ch. 14	Coronary artery disease detection : pharmacologic stress	233
Ch. 15	Prognostic applications of myocardial perfusion imaging : exercise stress	255
Ch. 16	Prognostic value of pharmacologic stress myocardial perfusion scintigraphy and its use in risk stratification	265
Ch. 17	Myocardial perfusion imaging using nonradionuclide techniques	281
Ch. 18	Cost effectiveness of myocardial perfusion single-photon emission computed tomography	297
Ch. 19	Imaging in women	311
Ch. 20	Imaging for preoperative risk stratification	323
Ch. 21	Nuclear imaging in patients with a history of coronary revascularization	339
Ch. 22	Stress myocardial pefusion imaging in patients with diabetes mellitus	349
Ch. 23	Radionuclide imaging in heart failure and cardiomyopathies	357
Ch. 24	Imaging in patients receiving cardiotoxic chemotherapy	377
Ch. 25	Mechanistic and methodologic considerations for the imaging of mental stress ischemia	385
Ch. 26	Measurement of myocardial blood flow and monitoring therapy	399
Ch. 27	Imaging patients with chest pain in the emergency department	415
Ch. 28	Measuring the efficacy of therapy in acute myocardial infarction with technetium-99m-sestamibi imaging	429
Ch. 29	Risk stratification after acute ST-segment elevation myocardial infarction	453
Ch. 30	Risk stratification in acute coronary syndromes	479
Ch. 31	Physiologic and metabolic basis of myocardial viability imaging	495
Ch. 32	Assessment of myocardial viability with thallium-201 and technetium-based agents	503
Ch. 33	Assessment of myocardial viability with positron emission tomography	519
Ch. 34	Comparison with non-nuclear techniques	535
Ch. 35	Fatty acid imaging	559
Ch. 36	Cardiac neurotransmission imaging : single-photon emission computed tomography	577
Ch. 37	Cardiac neurotransmission imaging : positron emission tomography	593
Ch. 38	Receptor imaging	609
Ch. 39	New molecular approaches for imaging of angiogenesis and hypoxia	631
Ch. 40	Noninvasive detection of cell death in myocardial disorders	649
Ch. 41	Radionuclide approach to imaging of inflammation in atheroma for the detection of lesions vulnerable to rupture	659
Ch. 42	Molecular imaging of gene products	673
Ch. 43	Imaging myocardial inflammation	691
	Case examples for use of myocardial perfusion imaging	699